Seeking Alpha

AEGR
  Aegerion Pharmaceuticals - NASDAQ

10/23/2014, 8:29 AM ET
52wk high:  
52wk low:  
EPS:  
PE (ttm):  
Div Rate:  
Yield:  
Market Cap:  
Volume:  
AEGR vs. ETF Alternatives
Company Description
Aegerion Pharmaceuticals, Inc. is a biopharmaceutical company. The Company currently operates in one business segment focusing on the development and commercialization of its product, lomitapide.
Sector: Healthcare
Industry: Biotechnology
Country: United States